Few researchers have explored the benefits of microdosing cannabis until now.
Microdosing marijuana offers pain patients an alternative method to reduce symptoms without receiving the plant’s psychoactive components, a new Israeli study found. The clinical trial offers some of the first scientific insights into the efficacy of microdosing marijuana and could represent a new relief for patients who don’t like or aren’t suited for the traditional “high” associated with cannabis.
You probably recognize the term microdosing for its association with psychedelics, particularly in microdosing psilocybin mushrooms or LSD. A microdose is generally considered a subtherapeutic uptake of a drug. Put more plainly, it’s when you use a drug but don’t experience the mind-altering sensation.
Though the trend received serious attention in Silicon Valley communities, scientific research doesn’t support the anecdotal claims made by those microdosing psychedelics. But few researchers have explored the benefits of microdosing cannabis until now.
Traditionally, pain patients establish their own medical cannabis doses through a faulty trial-and-error process. No traditional dose of THC, the psychoactive component in marijuana, exists. The National Institute on Drug Abuse (NIDA) actually requested help from the scientific community to standardize a unit dose of THC earlier this year.
Copyright
© 420 Intel